![Hemant Misra](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hemant Misra
Corporate Officer/Principal bei Prolong Pharmaceuticals LLC
Aktive Positionen von Hemant Misra
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Prolong Pharmaceuticals LLC
![]() Prolong Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Prolong Pharmaceuticals LLC develops and manufactures biopharmaceutical products to treat anemias, cancers and their debilitating comorbidities. The firm focuses on sickle cell anemia, diabetic ischemia, and several trauma indications. Its products include SANGUINATE, an oxygen transfer agent to treat anemia and protein therapeutics. The company was founded by Abraham Abuchowski in 2002 and is headquartered in South Plainfield, NJ. | Corporate Officer/Principal | 27.01.2011 | - |
Karriereverlauf von Hemant Misra
Ehemalige bekannte Positionen von Hemant Misra
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ActiveCyte, Inc. | Corporate Officer/Principal | - | - |
REVO BIOLOGICS INC | Corporate Officer/Principal | - | - |
Statistik
International
Vereinigte Staaten | 4 |
Operativ
Corporate Officer/Principal | 3 |
Sektoral
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Prolong Pharmaceuticals LLC
![]() Prolong Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Prolong Pharmaceuticals LLC develops and manufactures biopharmaceutical products to treat anemias, cancers and their debilitating comorbidities. The firm focuses on sickle cell anemia, diabetic ischemia, and several trauma indications. Its products include SANGUINATE, an oxygen transfer agent to treat anemia and protein therapeutics. The company was founded by Abraham Abuchowski in 2002 and is headquartered in South Plainfield, NJ. | Health Technology |
ActiveCyte, Inc. | |
rEVO Biologics, Inc.
![]() rEVO Biologics, Inc. BiotechnologyHealth Technology rEVO Biologics, Inc. engages in the development and commercialization of specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions. Its products include ATryn, which prevents blood clots during and after surgery and childbirth for patients with hereditary antithrombin deficiency. The company was founded in February 1993 and is headquartered in Framingham, MA. | Health Technology |
- Börse
- Insiders
- Hemant Misra
- Erfahrung